Soluble epoxide hydrolase dimerization is required for hydrolase activity

Journal of Biological Chemistry

Volumn 288, Issue 11, 2013, Pages 7697-7703

  Nelson, Jonathan W ^a,b   Subrahmanyan, Rishi M ^a   Summers, Sol A ^a   Xiao, Xiangshu ^b   Alkayed, Nabil J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIO-VASCULAR DISEASE; ENZYMATIC ACTIVITIES; EPOXIDE HYDROLASES; HYDROLASE ACTIVITIES; METABOLIC CONVERSION; SUBSTRATE CONVERSION; THERAPEUTIC STRATEGY; THERAPEUTIC TARGETS;

ENZYME ACTIVITY; HYDROLASES; PROTEINS;

DIMERIZATION;

EPOXIDE HYDROLASE; FIREFLY LUCIFERASE;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME POLYMORPHISM; ENZYME STABILITY; FLUORESCENCE ANALYSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; WILD TYPE;

8,11,14-EICOSATRIENOIC ACID; DIMERIZATION; DNA MUTATIONAL ANALYSIS; EPOXIDE HYDROLASES; GENETIC COMPLEMENTATION TEST; HEK293 CELLS; HUMANS; HYDROLASES; KINETICS; MODELS, MOLECULAR; MUTATION; POLYMORPHISM, GENETIC; SOLUBILITY; TRANSFECTION;

EID: 84875180857     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.429258     Document Type: Article

References (20)

1. Newman, J. W., Morisseau, C., Harris, T. R., and Hammock, B. D. (2003) The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc. Natl. Acad. Sci. U.S.A. 100, 1558-1563
2. Cronin, A., Mowbray, S., Dürk, H., Homburg, S., Fleming, I., Fisslthaler, B., Oesch, F., and Arand, M. (2003) The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc. Natl. Acad. Sci. U.S.A. 100, 1552-1557
3. Iliff, J. J., and Alkayed, N. J. (2009) Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol. 4, 179-199
4. Zhang, W., Otsuka, T., Sugo, N., Ardeshiri, A., Alhadid, Y. K., Iliff, J. J., DeBarber, A. E., Koop, D. R., and Alkayed, N. J. (2008) Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39, 2073-2078
5. Zhang, W., Koerner, I. P., Noppens, R., Grafe, M., Tsai, H. J., Morisseau, C., Luria, A., Hammock, B. D., Falck, J. R., and Alkayed, N. J. (2007) Soluble epoxide hydrolase: a novel therapeutic target in stroke. J. Cereb. Blood Flow Metab. 27, 1931-1940
6. Przybyla-Zawislak, B. D., Srivastava, P. K., Vazquez-Matias, J., Mohrenweiser, H. W., Maxwell, J. E., Hammock, B. D., Bradbury, J. A., Enayetallah, A. E., Zeldin, D. C., and Grant, D. F. (2003) Polymorphisms in human soluble epoxide hydrolase. Mol. Pharmacol. 64, 482-490
7. Argiriadi, M. A., Morisseau, C., Hammock, B. D., and Christianson, D. W. (1999) Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. Proc. Natl. Acad. Sci. U.S.A. 96, 10637-10642
8. Srivastava, P. K., Sharma, V. K., Kalonia, D. S., and Grant, D. F. (2004) Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure. Arch. Biochem. Biophys. 427, 164-169
9. Jones, P. D., Wolf, N. M., Morisseau, C., Whetstone, P., Hock, B., and Hammock, B. D. (2005) Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Anal. Biochem. 343, 66-75
10. Jiang, Y., Bernard, D., Yu, Y., Xie, Y., Zhang, T., Li, Y., Burnett, J. P., Fu, X., Wang, S., and Sun, D. (2010) Split Renilla luciferase protein fragmentassisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions. J. Biol. Chem. 285, 21023-21036
11. Luker, K. E., Smith, M. C. P., Luker, G. D., Gammon, S. T., Piwnica-Worms, H., and Piwnica-Worms, D. (2004) Kinetics of regulated proteinprotein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. U.S.A. 101, 12288-12293
12. Ohtoshi, K., Kaneto, H., Node, K., Nakamura, Y., Shiraiwa, T., Matsuhisa, M., and Yamasaki, Y. (2005) Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem. Biophys. Res. Commun. 331, 347-350
13. Burdon, K. P., Lehtinen, A. B., Langefeld, C. D., Carr, J. J., Rich, S. S., Freedman, B. I., Herrington, D., and Bowden, D. W. (2008) Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab. Vasc. Dis. Res. 5, 128-134
14. Zhang, L., Ding, H., Yan, J., Hui, R., Wang, W., Kissling, G. E., Zeldin, D. C., and Wang, D. W. (2008) Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population. Pharmacogenet. Genomics 18, 45-51
15. Lee, C. R., Pretorius, M., Schuck, R. N., Burch, L. H., Bartlett, J., Williams, S. M., Zeldin, D. C., and Brown N. J. (2011) Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans. Hypertension 57, 116-122
16. Kumar, S., and Nussinov, R. (2002) Relationship between ion pair geometries and electrostatic strengths in proteins. Biophys. J. 83, 1595-1612
17. Hu, C. D., Chinenov, Y., and Kerppola, T. K. (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789-798
18. Jester, B. W., Cox, K. J., Gaj, A., Shomin, C. D., Porter, J. R., and Ghosh, I. (2010) A coiled-coil enabled split-luciferase three-hybrid system: applied toward profiling inhibitors of protein kinases. J. Am. Chem. Soc. 132, 11727-11735
19. Costantini, S., Colonna, G., and Facchiano, A. M. (2008) ESBRI: a web server for evaluating salt bridges in proteins. Bioinformation 3, 137-138
20. Imig, J. D., and Hammock, B. D. (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discov. 8, 794-805